Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice
Open Access
- 1 September 2020
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 529 (7), 1327-1371
- https://doi.org/10.1002/cne.25023
Abstract
We used behavioral testing and morphological methods to detail the progression of basal ganglia neuron type‐specific pathology and the deficits stemming from them in male heterozygous Q175 mice, compared to age‐matched WT males. A rotarod deficit was not present in Q175 mice until 18 months, but increased open field turn rate (reflecting hyperkinesia) and open field anxiety were evident at 6 months. No loss of striatal neurons was seen out to 18 months, but ENK+ and DARPP32+ striatal perikarya were fewer by 6 months, due to diminished expression, with further decline by 18 months. No reduction in SP+ striatal perikarya or striatal interneurons was seen in Q175 mice at 18‐months, but cholinergic interneurons showed dendrite attenuation by 6 months. Despite reduced ENK expression in indirect pathway striatal perikarya, ENK‐immunostained terminals in globus pallidus externus (GPe) were more abundant at 6 months, and remained so out to 18 months. Similarly, SP‐immunostained terminals from striatal direct pathway neurons were more abundant in globus pallidus internus and substantia nigra at 6 months, and remained so at 18 months. FoxP2+ arkypallidal GPe neurons and subthalamic nucleus neurons were lost by 18 months but not prototypical PARV+ GPe neurons or dopaminergic nigral neurons. Our results show that striatal projection neuron abnormalities and behavioral abnormalities reflecting them develop between 2 and 6 months of age in Q175 male heterozygotes, indicating early effects of the HD mutation. The striatal pathologies resemble those in human HD, but are less severe at 18 months than even in premanifest HD.Keywords
Funding Information
- Cure Huntington's Disease Initiative (A‐8299, A14061)
This publication has 215 references indexed in Scilit:
- Dichotomous Organization of the External Globus PallidusNeuron, 2012
- Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imagingNeuroImage, 2012
- Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse modelNeuroImage, 2011
- Localization of cerebellin‐2 in late embryonic chicken brain: Implications for a role in synapse formation and for brain evolutionJournal of Comparative Neurology, 2011
- Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeatsExperimental Neurology, 2010
- Early atrophy of pallidum and accumbens nucleus in Huntington’s diseaseZeitschrift für Neurologie, 2010
- Immunohistochemical localization of AMPA-type glutamate receptor subunits in the striatum of rhesus monkeyBrain Research, 2010
- Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing FactorsJournal of Biological Chemistry, 2009
- Huntington disease models and human neuropathology: similarities and differencesActa Neuropathologica, 2007
- Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s diseaseProceedings of the National Academy of Sciences, 2006